Streetbeat News

Stock Prices

XPON

Expion360 (NASDAQ:XPON) is scheduled to release its quarterly earnings report on March 28, 2024, with analysts expecting an EPS of $-0.28. The company's past earnings performance shows a pattern of not meeting EPS estimates, leading to significant stock price drops the following day. Shares are currently trading at $3.34, reflecting a 44.98% decrease over the last year. Investors are looking for positive guidance for the next quarter to potentially boost the stock price.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 3:01 pm

CPTN

Cepton (NASDAQ:CPTN) is scheduled to release its quarterly earnings report on March 28, 2024, with an expected EPS of $-0.74. Analysts and investors will be closely watching for not only an earnings beat but also positive future guidance. Cepton's past earnings performance shows a mixed impact on its stock price, with the last quarter's beat followed by a 4.76% drop. Currently, Cepton's shares are trading at $2.74, marking a 40.9% decrease over the last year, indicating a negative sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 3:01 pm

AWH

Aspira Womens Health (NASDAQ:AWH) is scheduled to release its quarterly earnings report on March 28, 2024, with analysts predicting an EPS of $-0.45. The company's past earnings performance shows a pattern of beating EPS estimates but experiencing a subsequent drop in share price. Over the last year, AWH shares have declined by 39.24%, trading at $3.5 as of March 26. Investors are looking for positive guidance for the next quarter beyond the earnings beat.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 3:01 pm

FORA

Forian (NASDAQ:FORA) is scheduled to release its quarterly earnings report on Thursday, 2024-03-28, with an expected EPS of $-0.03. Analysts and investors are keen on not just the earnings beat or miss but also the company's guidance for future growth. Historically, Forian has had mixed earnings performance, with a notable beat last quarter leading to an 8.33% share price increase. However, over the last year, FORA shares have declined by 10.53%, indicating potential concerns among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 3:01 pm

AXDX

Accelerate Diagnostics (NASDAQ:AXDX) is scheduled to release its quarterly earnings report on March 28, 2024, with analysts expecting an EPS of $-0.62. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter's miss resulting in a 2.88% drop. Shares are currently trading at $0.9603, marking an 86.34% decline over the last year. Investors are looking for positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 3:01 pm

DOGEUSD

Dogecoin (CRYPTO: DOGE) saw a 4.07% increase in price over the last 24 hours, reaching $0.19. This is part of a larger trend, with a 37.0% gain over the past week from $0.13. The coin's all-time high is $0.73. Trading volume for Dogecoin has increased by 24.0% over the past week, and its circulating supply has risen by 0.03% to 143.62 billion, making its market cap $26.58 billion and ranking it #9.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 3:01 pm

LFLY

Leafly Holdings (NASDAQ:LFLY) is scheduled to release its quarterly earnings report on Thursday, 2024-03-28, with analysts estimating an EPS of $-1.45. The company's past earnings performance shows a mix of misses and beats against estimates, with varying impacts on its stock price. Currently trading at $3.3, LFLY shares have declined 51.53% over the last 52 weeks. Investors are looking for positive guidance for the next quarter, which could significantly influence the stock's price movement.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 3:01 pm

FDX

Analysts have diverse opinions on FedEx (NYSE:FDX), with recent evaluations showing a mix of ratings from bullish to bearish. The average 12-month price target for FDX is $295.06, marking a 5.68% increase from the previous target. Analyst actions include rating changes and price target adjustments, reflecting their views on FedEx's market performance and financial health. FedEx's financial indicators suggest a strong market position, despite a -1.94% decline in revenue growth over the last 3 months.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 3:01 pm

STLA

Financial giants have shown a mixed sentiment on Stellantis (NYSE:STLA) options, with 50% bullish and 50% bearish trades. The trades indicate a targeted price range of $22.0 to $40.0 for STLA. The company, formed from the merger of Fiat Chrysler and PSA Group, is the world's fifth-largest automaker. Currently, STLA's stock price is up by 0.84% at $28.94, with an anticipated earnings release in 119 days. The options trading activity and the company's market position suggest a nuanced outlook.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 3:01 pm

AFMD

Affimed (NASDAQ:AFMD) is scheduled to release its quarterly earnings report on March 28, 2024, with analysts expecting an EPS of $-1.68. The company's past performance shows a pattern of beating EPS estimates, leading to significant share price movements. Shares are currently trading at $5.32, down 25.35% over the last year. Investors are keen on the upcoming earnings and particularly on the guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 3:01 pm